FORUMS
Educating and training scientists on how the Center’s resources can aid their research
Forums are currently conducted in person and on Zoom. Please get in touch with our administrative manager to request an invite.
Request an invite
Upcoming Forums
March 21, 2025. CT-based Body Composition: The Sky is the Limit
Dr. Kirti Magudia will demonstrate how CT-based body composition analysis techniques using deep learning provide quantification of skeletal muscle, visceral fat, and subcutaneous fat, which have been correlated with overall survival, cancer-related outcomes, and cardiovascular events, among other clinical outcomes.
Past Forums
Concepts and Methods to Improve Validity of In Silico Trials – Experiences from Clinical Practice
(July 15, 2022) Doris Fuertinger from Fresenius Medical Care shows how patient-level data can be used to create large cohorts of individual virtual representations of patients and improve on the external validity of Virtual Clinical Trials (VCT).Usage of the XCAT Phantom to Investigate Respiratory Motion and Estimation of Attenuation Maps in Pediatric SPECT DMSA Studies
(June 17, 2022) Justin Pijanowski and Clifford Lindsay from the UMass Chan Medical School discuss their efforts in addressing image degradation in pediatric DMSA SPECT images in two areas, specifically patient motion and attenuation estimation with the use of CT.Beyond Anatomic Imaging: Seeing More with X-rays
(May 20, 2022) Ioannis Sechopoulos from Radboud University presents on methods used to transform CT into a functional imaging modality for which accurate human and image modeling are key.Reverse Engineering the Human (and Machine) Observer: Motivations and Tools
(April 22, 2022) Craig Abbey from the University of California, Santa Barbara describes a psychophysical methodology that has proven useful for understanding how human observers extract basic features related to task performance in noisy images.Virtual Imaging Perspectives from the FDA
(March 18, 2022) Andreu Badal of the US FDA gives an introduction to FDA evaluation of x-ray imaging systems and image processing software. He also discusses the FDA Medical Device Development Tool program and other mechanisms that the FDA is considering for use of virtual imaging in regulatory submissions.
